271 related articles for article (PubMed ID: 16079992)
1. Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems.
Viganò D; Rubino T; Vaccani A; Bianchessi S; Marmorato P; Castiglioni C; Parolaro D
Psychopharmacology (Berl); 2005 Nov; 182(4):527-36. PubMed ID: 16079992
[TBL] [Abstract][Full Text] [Related]
2. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
Chen SR; Pan HL
J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
[TBL] [Abstract][Full Text] [Related]
3. Mu opioid receptor signaling in morphine sensitization.
Viganò D; Rubino T; Di Chiara G; Ascari I; Massi P; Parolaro D
Neuroscience; 2003; 117(4):921-9. PubMed ID: 12654343
[TBL] [Abstract][Full Text] [Related]
4. Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats.
Stoller DC; Sim-Selley LJ; Smith FL
Brain Res; 2007 Apr; 1142():28-36. PubMed ID: 17300766
[TBL] [Abstract][Full Text] [Related]
5. Sex-dependent effects of periadolescent exposure to the cannabinoid agonist CP-55,940 on morphine self-administration behaviour and the endogenous opioid system.
Biscaia M; Fernández B; Higuera-Matas A; Miguéns M; Viveros MP; García-Lecumberri C; Ambrosio E
Neuropharmacology; 2008 Apr; 54(5):863-73. PubMed ID: 18329053
[TBL] [Abstract][Full Text] [Related]
6. Mu-opioid receptors are involved in the tolerance to nicotine antinociception.
Galeote L; Kieffer BL; Maldonado R; Berrendero F
J Neurochem; 2006 Apr; 97(2):416-23. PubMed ID: 16539669
[TBL] [Abstract][Full Text] [Related]
7. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA; Selley DE; Sim-Selley LJ; Welch SP
Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of mu opioid receptor/G-protein desensitization in brain by chronic heroin administration.
Maher CE; Martin TJ; Childers SR
Life Sci; 2005 Jul; 77(10):1140-54. PubMed ID: 15890372
[TBL] [Abstract][Full Text] [Related]
9. Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats.
Rubino T; Viganò D; Costa B; Colleoni M; Parolaro D
J Neurochem; 2000 Dec; 75(6):2478-84. PubMed ID: 11080200
[TBL] [Abstract][Full Text] [Related]
10. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
Solinas M; Goldberg SR
Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive activity of chemical congeners of improgan: optimization of side chain length leads to the discovery of a new, potent, non-opioid analgesic.
Hough LB; de Esch IJ; Janssen E; Phillips J; Svokos K; Kern B; Trachler J; Abood ME; Leurs R; Nalwalk JW
Neuropharmacology; 2006 Sep; 51(3):447-56. PubMed ID: 16806300
[TBL] [Abstract][Full Text] [Related]
12. Enhanced morphine withdrawal and micro -opioid receptor G-protein coupling in A2A adenosine receptor knockout mice.
Bailey A; Davis L; Lesscher HM; Kelly MD; Ledent C; Hourani SM; Kitchen I
J Neurochem; 2004 Feb; 88(4):827-34. PubMed ID: 14756803
[TBL] [Abstract][Full Text] [Related]
13. Effect of strain and sex on mu opioid receptor-mediated G-protein activation in rat brain.
Selley DE; Herbert JT; Morgan D; Cook CD; Picker MJ; Sim-Selley LJ
Brain Res Bull; 2003 May; 60(3):201-8. PubMed ID: 12754081
[TBL] [Abstract][Full Text] [Related]
14. Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940.
Rubino T; Viganò D; Massi P; Parolaro D
J Neurochem; 2000 Nov; 75(5):2080-6. PubMed ID: 11032897
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic treatment with citalopram on cannabinoid and opioid receptor-mediated G-protein coupling in discrete rat brain regions.
Hesketh SA; Brennan AK; Jessop DS; Finn DP
Psychopharmacology (Berl); 2008 May; 198(1):29-36. PubMed ID: 18084745
[TBL] [Abstract][Full Text] [Related]
16. Chronic neuropathic pain in mice reduces μ-opioid receptor-mediated G-protein activity in the thalamus.
Hoot MR; Sim-Selley LJ; Selley DE; Scoggins KL; Dewey WL
Brain Res; 2011 Aug; 1406():1-7. PubMed ID: 21762883
[TBL] [Abstract][Full Text] [Related]
17. [(35)S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord.
Madia PA; Navani DM; Yoburn BC
Pharmacol Biochem Behav; 2012 Mar; 101(1):155-65. PubMed ID: 22108651
[TBL] [Abstract][Full Text] [Related]
18. Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala.
Narita M; Kaneko C; Miyoshi K; Nagumo Y; Kuzumaki N; Nakajima M; Nanjo K; Matsuzawa K; Yamazaki M; Suzuki T
Neuropsychopharmacology; 2006 Apr; 31(4):739-50. PubMed ID: 16123756
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic ethanol and withdrawal on the mu-opioid receptor- and 5-Hydroxytryptamine(1A) receptor-stimulated binding of [(35)S]Guanosine-5'-O-(3-thio)triphosphate in the fawn-hooded rat brain: A quantitative autoradiography study.
Chen F; Lawrence AJ
J Pharmacol Exp Ther; 2000 Apr; 293(1):159-65. PubMed ID: 10734165
[TBL] [Abstract][Full Text] [Related]
20. Chronic morphine administration results in tolerance to delta opioid receptor-mediated antinociception.
Pradhan AAA; Siau C; Constantin A; Clarke PBS
Neuroscience; 2006 Aug; 141(2):947-954. PubMed ID: 16716526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
